The Case for Intravenous Arginine Stimulation In Lieu of Mixed-Meal Tolerance Tests as Outcome Measure for Intervention Studies in Recent-Onset Type 1 Diabetes
- 1 May 2004
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 27 (5) , 1202-1204
- https://doi.org/10.2337/diacare.27.5.1202
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Differential β-cell response to glucose, glucagon, and arginine during progression to type I (insulin-dependent) diabetes mellitusMetabolism, 1996
- Acute insulin response to intravenous glucose, glucagon and arginine in some subjects at risk for Type 1 (insulin-dependent) diabetes mellitusDiabetologia, 1991
- Correlations of in vivo beta-cell function tests with beta-cell mass and pancreatic insulin content in streptozocin-administered baboonsDiabetes, 1991
- Endocrine-metabolic function in remission-phase IDDM during administration of cyclosporineDiabetes, 1991
- Reproducibility of the Glucagon TestDiabetic Medicine, 1987
- Differential sensitivity to beta-cell secretagogues in "early," type I diabetes mellitusDiabetes, 1984
- C-Peptide response to arginine stimulation in diabetic childrenThe Journal of Pediatrics, 1980
- C-peptide secretion during the remission phase of juvenile diabetesDiabetes, 1978
- C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitusDiabetes, 1977
- Abnormalities of endogenous glucagon and insulin in unstable diabetesDiabetes, 1977